These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15076018)

  • 1. Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results.
    Ahn YM; Jeong SH; Jang HS; Koo YJ; Kang UG; Lee KY; Kim YS
    Int Clin Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 15076018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
    BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium and clozapine-induced neutropenia/agranulocytosis.
    Blier P; Slater S; Measham T; Koch M; Wiviott G
    Int Clin Psychopharmacol; 1998 May; 13(3):137-40. PubMed ID: 9690982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients.
    McKee JR; Wall T; Owensby J
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):26-32. PubMed ID: 21459736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D
    Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
    Lau KL; Yim PH
    East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuation of Treatment With Clozapine After an Episode of Neutropenia.
    Tirupati S; Gordon T
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):320-322. PubMed ID: 33657071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuing clozapine treatment despite neutropenia.
    Esposito D; Rouillon F; Limosin F
    Eur J Clin Pharmacol; 2005 Jan; 60(11):759-64. PubMed ID: 15660271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine-induced neutropenia in children: management with lithium carbonate.
    Sporn A; Gogtay N; Ortiz-Aguayo R; Alfaro C; Tossell J; Lenane M; Gochman P; Rapoport JL
    J Child Adolesc Psychopharmacol; 2003; 13(3):401-4. PubMed ID: 14642024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematological and cardiometabolic safety of clozapine in the treatment of very early onset schizophrenia: a retrospective chart review.
    Midbari Y; Ebert T; Kosov I; Kotler M; Weizman A; Ram A
    J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):516-21. PubMed ID: 24111981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case study; ethnicity and clozapine, a risky combination?].
    Laan WJ; Ramlal D
    Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
    J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematological adverse events in clozapine-treated children and adolescents.
    Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
    J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic benign neutropenia/agranulocytosis associated with non-clozapine antipsychotics.
    Vila-Rodriguez F; Tsang P; Barr AM
    Am J Psychiatry; 2013 Oct; 170(10):1213-4. PubMed ID: 24084822
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuing clozapine despite neutropenia.
    Wesson ML; Finnegan DM; Clark PI
    Br J Psychiatry; 1996 Feb; 168(2):217-20. PubMed ID: 8837913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L; Cazard F
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haematological side effects of clozapine: patient characteristics.
    Miller PR; Cutten AE
    N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximizing clozapine utilization while minimizing blood dyscrasias: evaluation of patient demographics and severity of events.
    Demler TL; Morabito NE; Meyer CE; Opler L
    Int Clin Psychopharmacol; 2016 Mar; 31(2):76-83. PubMed ID: 26565383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E; Taylor D
    CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia.
    Maher KN; Tan M; Tossell JW; Weisinger B; Gochman P; Miller R; Greenstein D; Overman GP; Rapoport JL; Gogtay N
    J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):110-6. PubMed ID: 23510445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.